Abira Medical Laboratories

Abira Medical Laboratories was paid $1.76M by Medicaid between Jan 2018 and Aug 2021, across 191 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 74% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Pennsylvania

Rank by total paid#17 of 95

Median peer was paid$153K

This provider vs. median12×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	42,512	$52K
2019	106,329	$121K
2020	82,555	$1.14M
2021	35,753	$452K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	74%	36,318	14,740	$1.31M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	3.9%	8,242	3,338	$70K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	3.5%	1,426	1,185	$62K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	2.5%	727	643	$44K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	1.3%	1,073	735	$23K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	1.0%	2,907	2,318	$18K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	2,833	2,244	$16K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	3,824	3,269	$10K
87481		<1%	1,097	922	$9K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	583	478	$7K
84443	Thyroid stimulating hormone (TSH)	<1%	6,188	4,798	$7K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	9,238	7,421	$5K

179 more codes

87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	1,116	$5K
80050	General health panel	<1%	2,699	$5K
83970		<1%	1,838	$5K
85027		<1%	7,689	$5K
87640		<1%	1,313	$5K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	1,786	$4K
80053	Comprehensive metabolic panel	<1%	4,645	$4K
84403		<1%	2,043	$4K
87653		<1%	1,300	$4K
87641		<1%	852	$4K
87486		<1%	780	$4K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	116	$4K
87541		<1%	713	$4K
83036	Hemoglobin; glycosylated (A1C)	<1%	4,407	$4K
82670		<1%	1,685	$4K
84146		<1%	2,325	$3K
87340		<1%	1,759	$3K
87581		<1%	558	$3K
82542		<1%	2,737	$3K
87500		<1%	673	$3K
82627		<1%	1,826	$3K
80061	Lipid panel	<1%	2,369	$3K
84270		<1%	1,952	$3K
87498		<1%	581	$3K
87496		<1%	581	$3K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	614	$3K
84144		<1%	1,736	$3K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	597	$3K
82607		<1%	2,105	$2K
83001		<1%	1,702	$2K
83090		<1%	1,539	$2K
83002		<1%	1,640	$2K
86803		<1%	2,041	$2K
82746		<1%	1,830	$2K
86141		<1%	1,581	$2K
83880		<1%	371	$2K
80074		<1%	221	$2K
87561		<1%	549	$2K
85049		<1%	6,442	$2K
87503		<1%	584	$2K
86706		<1%	1,871	$2K
85014		<1%	7,476	$2K
80048	Basic metabolic panel (calcium, ionized)	<1%	1,891	$2K
82728		<1%	1,517	$2K
82947		<1%	4,510	$1K
87556		<1%	551	$1K
84466		<1%	1,464	$1K
87088		<1%	1,150	$1K
86696		<1%	601	$1K
86001		<1%	2,484	$1K
83735		<1%	2,596	$1K
83525		<1%	787	$1K
80076		<1%	1,519	$1K
84153		<1%	643	$1K
84550		<1%	2,658	$1K
84481		<1%	844	$1K
82105		<1%	597	$1K
85018		<1%	7,496	$989.55
86762		<1%	834	$962.59
83701		<1%	729	$887.56
86431		<1%	1,848	$854.85
84439		<1%	1,265	$842.10
86708		<1%	921	$839.81
86704		<1%	969	$836.46
86695		<1%	587	$823.51
83690		<1%	1,463	$817.17
82150		<1%	1,482	$803.99
82172		<1%	438	$748.08
84702		<1%	565	$731.43
83540		<1%	1,734	$724.53
82977		<1%	1,161	$662.48
84402		<1%	421	$660.84
84100		<1%	1,605	$651.55
89060		<1%	1,350	$638.48
84436		<1%	1,129	$637.20
84480		<1%	625	$588.64
86592		<1%	1,057	$572.73
81001		<1%	3,072	$558.43
84479		<1%	1,078	$537.59
82565		<1%	2,053	$532.35
83986		<1%	2,742	$522.33
36415	Collection of venous blood by venipuncture	<1%	6,968	$485.58
83704		<1%	48	$482.40
81003		<1%	4,046	$458.09
86003		<1%	57	$454.98
82570		<1%	1,148	$443.26
82677		<1%	239	$441.93
84132		<1%	1,935	$395.91
86769		<1%	17	$386.39
87522	Neg quan hep c or qual rna	<1%	49	$386.33
82043		<1%	1,035	$364.15
84295		<1%	1,849	$341.78
83695		<1%	141	$340.67
86787		<1%	252	$340.38
87086	Culture, bacterial; quantitative colony count, urine	<1%	685	$326.90
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	121	$314.28
84520		<1%	1,933	$309.42
86336		<1%	239	$284.50
86870		<1%	417	$275.59
86709		<1%	169	$258.40
84460		<1%	1,498	$242.36
83721		<1%	1,159	$237.67
82040		<1%	1,805	$236.46
82550		<1%	137	$232.44
84450		<1%	1,270	$231.51
81000		<1%	2,817	$222.14
82157		<1%	88	$221.74
84075		<1%	1,268	$221.38
86886		<1%	397	$218.37
85652		<1%	749	$211.53
83550		<1%	1,661	$209.50
82310		<1%	1,293	$192.19
82374		<1%	1,254	$180.39
82248		<1%	471	$166.59
86905		<1%	393	$160.82
84156		<1%	588	$150.25
82533		<1%	105	$144.69
87631		<1%	30	$141.07
86901		<1%	543	$138.04
82435		<1%	1,257	$136.00
83498		<1%	93	$135.15
86900		<1%	514	$121.09
U0001	Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel	<1%	41	$118.85
86850		<1%	388	$116.93
83021		<1%	76	$103.81
86038		<1%	56	$81.66
86140		<1%	1,004	$79.30
86705		<1%	29	$67.14
82378		<1%	92	$65.76
84154		<1%	25	$63.54
86235		<1%	78	$50.43
84410		<1%	78	$47.49
86304		<1%	64	$45.10
82247		<1%	1,113	$44.74
86225		<1%	78	$43.48
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	31	$38.65
82785		<1%	32	$35.03
80178		<1%	30	$31.68
85730		<1%	106	$31.20
85610		<1%	175	$30.36
81241		<1%	100	$28.61
82951		<1%	63	$24.80
84155		<1%	1,905	$23.70
81015		<1%	1,282	$18.78
82952		<1%	37	$7.56
86376		<1%	29	$7.28
85041		<1%	41	$2.90
81400		0%	66	$0.00
81231		0%	99	$0.00
84478		0%	357	$0.00
81225		0%	99	$0.00
81226		0%	99	$0.00
84432		0%	14	$0.00
81350		0%	100	$0.00
81240		0%	99	$0.00
81230		0%	99	$0.00
81407		0%	28	$0.00
81227		0%	99	$0.00
0112U		0%	73	$0.00
81283		0%	100	$0.00
81511		0%	21	$0.00
81408		0%	166	$0.00
81291		0%	99	$0.00
82465		0%	435	$0.00
83718		0%	356	$0.00
81232		0%	100	$0.00
81355		0%	100	$0.00
81479	Unlisted molecular pathology procedure	0%	93	$0.00
81256		0%	66	$0.00
81335		0%	100	$0.00
81328		0%	99	$0.00
81406		0%	142	$0.00
81401		0%	101	$0.00
86480		0%	21	$0.00
81405		0%	27	$0.00
81404		0%	27	$0.00
83698		0%	13	$0.00
82610		0%	13	$0.00
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialVERNON, ELLIOTT (OWNER)